Core Scientific, Inc. [Rocket]

Overview

Core Scientific, Inc.

Add to portfolio

Recent News + Filings (All items)

Date Filed	Type	Description
09/29/2023	8-K	Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
08/08/2023	8-K	Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
08/04/2023	10-Q	Quarterly Report for the period ended June 30, 2023
07/31/2023	8-K	Quarterly results
07/06/2023	8-K	Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
06/30/2023	8-K	Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
06/08/2023	3	Sullivan Adam Taylor (President) has filed a Form 3 on Core Scientific, Inc./tx

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-21	Dec-31-20
Revenues	-0.2	60.3
Revenue growth	-100.3%
Cost of goods sold	0.0	50.9
Gross profit	-0.2	9.4
Gross margin	100.0%	15.6%
Sales and marketing		1.8
Research and development		5.3
General and administrative	4.8	14.6
EBIT	-5.2	-6.3
EBIT margin	2902.9%	-10.5%
Pre-tax income	-32.5	-12.2
Income taxes	0.0	0.0
Tax rate	0.0%	0.0%
Net income	-32.5	0.0
Net margin	18095.0%	0.0%

Diluted EPS	($1.06)	($0.23)
Shares outstanding (diluted)	30.5	0.1

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.